Scout Bio
Latest round
- Series B
Last raised
- Apr 2019
Total raised
- $20M
Investors
- 6
About Scout Bio
Established in 2016 by founder Krishna Polu and based in Pennsylvania, US, Scout Bio, Inc. focuses on creating one-time treatments for chronic health conditions in companion animals. The company leverages adeno-associated viral (AAV) vector technology to deliver therapeutic proteins to improve the lives of pets and their owners., a portfolio company of EMZ Partners, CDH Investments, Hopu Investment Management, NiXEN Partners, Merieux Equity Partners, Sagard, Natixis Investments, and Conti Ventures, acquired Advanced Micro Instruments, Inc. from Frazier Healthcare Partners, Greenspring Associates, RiverVest Ventures, Correlation Ventures, Adage Capital Management, and Digitalis Ventures. Scout Bio specializes in developing gene therapies designed to treat chronic conditions in pets with a single injection. The company's approach involves using AAV vector technology to express therapeutic proteins in vivo. This method provides benefits from a one-time treatment, addressing major health issues in pets. The firm therapy under development targets anaemia associated with chronic kidney disease (CKD) in cats. CKD is prevalent among older cats and leads to various complications, including anaemia. In addition to CKD-related anaemia, Scout Bio developing therapies for other chronic conditions including treatments for chronic arthritis pain in cats, which are in clinical trials.
Who invested in Scout Bio
6 investors across 1 round
See all investors in Scout Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 10, 2019
Amount
$20M
Investors
Questions about Scout Bio
Who invested in Scout Bio?
Scout Bio has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Scout Bio raised?
Scout Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Scout Bio last raise money?
Scout Bio's most recent round on record is a Series B, in Apr 2019.
What does Scout Bio do?
Established in 2016 by founder Krishna Polu and based in Pennsylvania, US, Scout Bio, Inc.
Where is Scout Bio headquartered?
Scout Bio is headquartered in Philadelphia, US.
Which VCs invest in companies like Scout Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Scout Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Scout Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.